Cora Capital Advisors’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$137K Buy
89,220
+44,500
+100% +$67.6K 0.04% 143
2026
Q1
$80.9K Buy
44,720
+14,577
+48% +$25.2K 0.03% 132
2025
Q4
$40.7K Buy
30,143
+6,500
+27% +$9.26K 0.02% 135
2025
Q3
$38.5K Buy
23,643
+7,000
+42% +$7.76K 0.02% 116
2025
Q2
$16.1K Hold
16,643
0.01% 111
2025
Q1
$11.8K Hold
16,643
0.01% 106
2024
Q4
$13.4K Sell
16,643
-10
-0.1% -$9 0.01% 104
2024
Q3
$16.5K Buy
16,653
+4,500
+37% +$6.18K 0.01% 101
2024
Q2
$18.8K Buy
+12,153
New +$18.9K 0.01% 95

Other funds holding OCGN

Cora Capital Advisors's OCGN Position: Q2 2026 in Review

Cora Capital Advisors increased its Ocugen (OCGN) stake by 100% in Q2 2026, buying an estimated $67.6K and bringing the position to 89,220 shares worth $137K. The position accounts for 0.04% of the portfolio, ranked #143.

Cora Capital Advisors first reported a position in OCGN in Q2 2024 and has held it in 9 quarters since. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Cora Capital Advisors held 89,220 shares of Ocugen worth $137K as of Q2 2026.
  • Cora Capital Advisors bought 44,500 Ocugen shares in Q2 2026, an estimated $67.6K.
  • Ocugen made up 0.04% of Cora Capital Advisors's portfolio in Q2 2026, its #143 holding.
  • Cora Capital Advisors first reported a position in Ocugen in Q2 2024 and has held it in 9 quarters since.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Cora Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.